Syra Health Corp. Class A (SYRA)
OTHER OTC:SYRA
Want to see SYRA full AI Analyst Report?
SYRA Stock Chart & Stats
$0.09
-$0.12(-16.06%)
At close: 4:00 PM EST
$0.09
-$0.12(-16.06%)
Day’s Range― - ―
52-Week Range$0.05 - $0.70
Previous CloseN/A
Volume2.20M
Average Volume (3M)9.76K
Market Cap
$4.63M
Enterprise Value$2.02M
Total Cash (Recent Filing)$2.92M
Total Debt (Recent Filing)$73.09K
Price to Earnings (P/E)2.7
Beta1.11
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding11,339,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap0.44
Enterprise Value/Revenue0.26
Enterprise Value/Gross Profit0.80
Enterprise Value/Ebitda-9.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthTTM revenue up ~575% reflects rapid expansion of services and tech adoption across public and behavioral health. Durable top-line growth improves unit economics and creates capacity for margin improvement, supporting a longer-term path to profitability if execution remains consistent.
Free Cash Flow TurnaroundFree cash flow turning positive after multi-year outflows demonstrates the business can generate operating cash. Sustainable FCF strengthens financial flexibility, reduces reliance on external funding, and enables reinvestment in product and delivery capabilities that support durable growth.
Low LeverageVery low debt (debt-to-equity ~0.03) signals conservative capital structure and lower financial risk. This gives management capacity to fund growth organically or pursue M&A, and it reduces interest burden, improving resilience through cyclical or execution-related headwinds.
Bears Say
Still UnprofitableNet margin (~-2.4% TTM) and ROE (~-8%) show the company has not yet converted growth into sustainable profitability. Persistent negative returns constrain retained capital, limit ability to self-fund expansion, and require continued margin improvement to secure a durable business model.
Cash-Flow VolatilityOperating and free cash flow have swung materially year-to-year, with large outflows in 2023–2024 and negative operating cash flow in 2025. Such volatility impedes reliable planning, increases refinancing risk, and means recent positive FCF must be sustained to be meaningful.
Execution RiskAnalyst scoring flags historical revenue and cash-flow volatility as execution risk. Rapid swings imply scaling challenges delivering complex public-health programs; without stronger operational controls and capacity, sustaining growth and margins over the next 2–6 months is uncertain.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.05 and its highest was $0.70 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $4.63M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is Aug 06, 2026 which is in 75 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on May 07, 2026. The company reported $0.019 earnings per share for the quarter, beating the consensus estimate of N/A by $0.019.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 11,339,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of $0.019 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―
Ownership Overview
Options Prices
Currently, No data available
---